The global outsourced testing services industry is anticipated to be worth US$ 36.4 billion in 2022 and to grow at a CAGR of 7.7% to US$ 76.3 billion by 2032. Pharma/biopharmaceutical testing will dominate the global market in 2021 with a share of 40.8%, according to a recent analysis by Future Market Insights.
The rise in the number of infectious as well as chronic diseases has led to the growth of the overall outsourced testing services market. With increase in such disease conditions, the volumes of testing are also rapidly increasing. The incidence of conditions like cardiac arrests, diabetes, cancer, stroke, and arthritis has been increasing at a higher rate. These cases have become one of the major causes of death globally.
Get Your Report Sample To Gain Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-15643
As per the worldwide cancer data from World Cancer Research Fund International, in 2020, there were 18.1 million cancer cases globally. Similarly, as per WHO, 2021 data, around 422 million people around the world have diabetes.
Thus with the rapid growth and high prevalence of these disease conditions, along with increased awareness of the patients, testing services are constantly in demand and increasing in preference.
In addition, with the rise in the number of service offerings for various different tests, the market is rapidly growing. The market is also seeing a rapid growth in emerging countries such as China and India.
Key Takeaways from Market Study:
- Pharma/biopharmaceuticals tests dominated the market with a 40.8% market share in the test segment of the outsourced testing services market in 2021.
- Contract research organizations by end user dominated the market in 2021 with a share of 51.5% of the outsourced testing services market.
- Europe dominates among the seven regions, with a market share of 32.3% in 2021.
“Limited In-house production capability, rising demand for testing and manufacturing services for bulk products and cost-effective of the outsourcing services is set to propel the sales of the outsourced testing services market across the globe,” says an analyst of Future Market Insights.
Elevate Your Understanding With Our Insightful Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15643
Market Competition:
The outsourced testing services market is highly fragmented because of the large number of key players in the market. There is a broad range of products that can be categorized under the outsourced testing services market; therefore, it is a broad market. The strategies that are majorly followed by the key players of the outsourced testing services market include product launches, expansions, collaborations and partnerships, and mergers and acquisitions.
- On March 8, 2021, Sotera acquired BioScience Laboratories, LLC with one location in Bozeman, Montana. BioScience is a provider of outsourced topical antimicrobial product testing in the pharmaceutical, medical device, and consumer industries. BioScience’s expertise in analytical testing and clinical trial services will complement Nelson Labs’ existing strengths in antimicrobial and virology testing.
- Labcorp announced the opening of a new, integrated bioanalytical laboratory in Singapore during the fourth quarter of 2021, expanding customer access in the Asia-Pacific region
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the outsourced testing services market in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 – 2032.
Key Companies Profiled:
- Eurofins Scientific
- Sotera Health (Nelson Labs)
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- IQVIA Inc.
- Elements Group (Element Materials Technology)
- Lucideon Limited
- Canadian Analytical Laboratories Inc.
- Intertek Group plc
- North American Science Associates, LLC
- WuXiAppTec
- Syneos Health
- Charles River Laboratories
- Parexel International Corporation
- West Pharmaceutical Services, Inc.
Customization Unleashed: Learn How to Stand Out in a Competitive Landscape: https://www.futuremarketinsights.com/customization-available/rep-gb-15643
Key Market Segments Covered in outsourced testing services Industry Research:
By Test Types:
- Pharma/Biopharmaceuticals
- Clinical Trials Testing
- Bioanalytical Testing
- Biocompatibility & Toxicology Testing
- Extractables & Leachables Testing
- Clinical Stability Testing
- Sterilization Testing
- Facility & Process Validation
- Medical Devices
- Clinical Trials Testing
- Bioanalytical Testing
- Biocompatibility & Toxicology Testing
- Chemical Characterization & Product Stability Testing
- Microbial & Sterility Testing
- Others
- Cosmetics
- Microbiological testing
- Stability testing
- Safety and Toxicological testing
- Performance Testing
- Compatibility testing with packaging
- Others
- Nutraceuticals
- Clinical Trials Testing
- Bioanalytical Testing
- Contamination Testing
- Allergen Testing
- Others
- Food & Beverage Testing
- Analytical Chemistry Testing
- Sensory Testing
- Nutrition Analysis
- Microbiology Testing
By End User:
- Contract Research Organization
- Contract Development And Manufacturing Organization
- Academic and Research Institutes
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
